ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

French Firm Incubates Italian Biotechnology

by Alex Scott
November 23, 2015 | APPEARED IN VOLUME 93, ISSUE 46

Sofinnova Partners, a Paris-based life sciences venture capital firm, has established a business to translate intellectual property into biotech start-ups in Italy. Sofinnova claims its new business, named BiovelocITA, is the first of its kind in the country. Sofinnova and a group of private investors have seeded BiovelocITA with more than $6 million. BiovelocITA is evaluating more than 10 projects including some from TTFactor, an organization representing major Italian research institutes. “There is a window of opportunity in Italy: The science is excellent, and the pool of entrepreneurs is growing,” says Graziano Seghezzi, a Sofinnova partner.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment